Related Experiment Video
Updated: May 5, 2026

Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Machine Learning-Derived Neddylation Gene Signature for Predicting Prognosis and Immunotherapy Benefits in Colorectal
Guangda Yang1, Jieming Xiao2, Huixiang He3
1Department of Cancer Chemotherapy, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511300, People's Republic of China.
This study identifies a neddylation-related gene signature (NRGS) that predicts colorectal cancer (CRC) patient outcomes and treatment response. The NRGS highlights potential therapeutic targets for improving CRC treatment resistance.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Colorectal cancer (CRC) poses a significant global health challenge due to treatment resistance.
- Neddylation, a post-translational modification, influences tumor progression and immune responses, but its role in CRC remains underexplored.
Purpose of the Study:
- To investigate the role of neddylation-related genes (NRGs) in colorectal cancer subtypes.
- To develop and validate a neddylation-related gene signature (NRGS) for predicting CRC patient prognosis and treatment response.
Main Methods:
- Analysis of CRC single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq data from TCGA and GEO databases.
- Development of an NRGS using ten machine-learning algorithms and external validation.
- Comparative analysis of biofunctions, immune cell infiltration, genomic mutations, and treatment responses between high- and low-risk groups.
Main Results:
- High neddylation scores in CRC are associated with increased malignant and diverse immune/stromal cells, promoting tumor growth and spread.
- Two distinct neddylation patterns were identified, with Cluster B linked to poorer survival, immunosuppression, and tumor progression.
- The developed NRGS accurately predicted overall survival (OS) with high AUC values and correlated with advanced disease stage, recurrence, and metastasis.
Conclusions:
- The NRGS effectively predicts prognosis and potential resistance to immunotherapy and chemotherapy in CRC patients.
- This signature can aid in developing personalized treatment strategies for colorectal cancer.
- Further validation is recommended to confirm the clinical utility of the NRGS.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase